Company facts
- Headquarters
- Switzerland
About
Umlaut.bio GmbH is a pioneering biotech company focused on developing first-in-biology therapies targeting cancer and inflammatory diseases. Small molecules under development inhibit key steps in tRNA modification thereby preventing overactivation of a multitude of signalling transduction pathways. This is a hallmark o…